in Newswire September 24, 2019

Class Action Lawsuit Alleges Recalled Allergan Biocell Breast Implants Increase Cancer Risk

by Corrado Rizzi

Last Updated on September 24, 2019

Tauben v. Allergan, Inc. et al.

Filed: September 20, 2019 § 2:19-cv-02257

Allergan faces a class action from an Illinois resident who claims she is at a higher risk of developing BIA-ALCL, a cancer of the immune system, from the company's now-recalled textured breast implants.




Last Updated on September 24, 2019 — 12:09 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.